FURFARO, FEDERICA

FURFARO, FEDERICA  

Facoltà di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 183 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 1-gen-2024 Cicerone, C.; D'Amico, F.; Allocca, M.; Zilli, A.; Parigi, T. L.; Danese, S.; Furfaro, F.
Abdominal pain after minor trauma in a patient with Crohn's disease 1-gen-2013 Maconi, G.; Monteleone, M.; Furfaro, F.; Bezzio, C.; Tonolini, M.; Sampietro, G.
Abdominal pain after minor trauma in a patient with Crohn's disease 1-gen-2013 Maconi, G; Monteleone, M; Furfaro, F; Bezzio, C; Tonolini, M; Sampietro, G
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures 1-gen-2020 Fiorino, G; Gilardi, D; Radice, S; Furfaro, F; Allocca, M; Danese, S
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps 1-gen-2016 Repici, A; Ciscato, C; Amato, L; Di Leo, M; Ferrara, E; Carrara, S; Anderloni, A; Galtieri, Pa; Sferrazza, S; Furfaro, F; Maselli, R; Carlani, E; Fiorino, G; Hassan, C
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 1-gen-2018 Allocca, M; Fiorino, G; Bonovas, S; Furfaro, F; Gilardi, D; Argollo, M; Magnoni, P; Peyrin-Biroulet, L; Danese, S
Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines 1-gen-2024 Sciberras, M; Farrugia, Y; Gordon, H; Furfaro, F; Allocca, M; Torres, J; Arebi, N; Fiorino, G; Iacucci, M; Verstockt, B; Magro, F; Katsanos, K; Busuttil, J; De Giovanni, K; Fenech, Va; Chetcuti Zammit, S; Ellul, P.
Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era 1-gen-2019 Iacucci, M; Furfaro, F; Matsumoto, T; Uraoka, T; Smith, S; Ghosh, S; Kiesslich, R
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 1-gen-2023 Goetsch, A.; D'Amico, F.; Allocca, M.; Fiorino, G.; Furfaro, F.; Zilli, A.; Parigi, T. L.; Radice, S.; Peyrin-Biroulet, L.; Danese, S.
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 1-gen-2025 Fasulo, E.; D'Amico, F.; Zilli, A.; Furfaro, F.; Cicerone, C.; Parigi, T. L.; Peyrin-Biroulet, L.; Danese, S.; Allocca, M.
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 1-gen-2025 Centanni, L.; Cicerone, C.; Fanizzi, F.; D'Amico, F.; Furfaro, F.; Zilli, A.; Parigi, T. L.; Peyrin-Biroulet, L.; Danese, S.; Allocca, M.
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 1-gen-2024 D'Amico, F.; Massimino, L.; Palmieri, G.; Dal Buono, A.; Gabbiadini, R.; Caron, B.; Moreira, P.; Silva, I.; Bosca-Watts, M.; Innocenti, T.; Dragoni, G.; Bezzio, C.; Zilli, A.; Furfaro, F.; Saibeni, S.; Chaparro, M.; Garcia, M. J.; Michalopoulos, G.; Viazis, N.; Mantzaris, G. J.; Ellul, P.; Gisbert, J. P.; Magro, F.; Peyrin-Biroulet, L.; Armuzzi, A.; Ungaro, F.; Danese, S.; Fiorino, G.; Allocca, M.
An Unusual Case of Cardiac Involvement in Crohn's Disease 1-gen-2021 Furfaro, F; Solitano, V; Danese, S
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease 1-gen-2017 Fiorino, G; Ruiz-Aguello, Mb; Maguregui, A; Nagore, D; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Martinez, A; Danese, S
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 1-gen-2021 Gabbiadini, R; Zacharopoulou, E; Furfaro, F; Craviotto, V; Zilli, A; Gilardi, D; Roda, G; Loy, L; Fiorino, G; Peyrin-Biroulet, L; Danese, S; Allocca, M
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future 1-gen-2022 Solitano, V.; Zilli, A.; Franchellucci, G.; Allocca, M.; Fiorino, G.; Furfaro, F.; D'Amico, F.; Danese, S.; Al Awadhi, S.
ASSESSMENT OF THE DISEASE EXTENSION IN CHILDREN AND ADOLESCENTS WITH IBD: COMPARISON OF BOWEL ULTRASOUND AND MAGNETIC RESONANCE ENTEROGRAPHY 1-gen-2014 Dilillo, D; Penagini, F; Maconi, G; Rendo, G; Tonolini, M; Meneghin, F; Furfaro, F; Zuccotti, Gv
Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? 1-gen-2019 Argollo, M; Fiorino, G; Gilardi, D; Furfaro, F; Roda, G; Loy, L; Allocca, M; Peyrin-Biroulet, L; Danese, S
Biosimilars of adalimumab: the upcoming challenge in IBD 1-gen-2019 Fiorino, G; Gilardi, D; Correale, C; Furfaro, F; Roda, G; Loy, L; Argollo, M; Allocca, M; Peyrin-Biroulet, L; Danese, S
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 1-gen-2021 Furfaro, F.; Buono, A. D.; Allocca, M.; D'Amico, F.; Zilli, A.; Gabbiadini, R.; Danese, S.